Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
Open Access
- 1 February 2019
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 9 (2) , 30
Abstract
In the last years, lysosomal storage diseases appear as a bridge of knowledge between rare genetic inborn metabolic disorders and neurodegenerative diseases such as Parkinson’s disease (PD) or frontotemporal dementia. Epidemiological studies helped promote research in the field that continues to improve our understanding of the link between mutations in the glucocerebrosidase (GBA) gene and PD. We conducted a review of this link, highlighting the association in GBA mutation carriers and in Gaucher disease type 1 patients (GD type 1). A comprehensive review of the literature from January 2008 to December 2018 was undertaken. Relevance findings include: (1) There is a bidirectional interaction between GBA and α- synuclein in protein homeostasis regulatory pathways involving the clearance of aggregated proteins. (2) The link between GBA deficiency and PD appears not to be restricted to α–synuclein aggregates but also involves Parkin and PINK1 mutations. (3) Other factors help explain this association, including early and later endosomes and the lysosomal-associated membrane protein 2A (LAMP-2A) involved in the chaperone-mediated autophagy (CMA). (4) The best knowledge allows researchers to explore new therapeutic pathways alongside substrate reduction or enzyme replacement therapies.Keywords
This publication has 97 references indexed in Scilit:
- The cognitive profile of type 1 Gaucher disease patientsJournal of Inherited Metabolic Disease, 2012
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1The EMBO Journal, 2010
- Gaucher disease ascertained through a Parkinson's center: Imaging and clinical characterizationMovement Disorders, 2010
- The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body DisordersCurrent Neurology and Neuroscience Reports, 2010
- The risk of Parkinson's disease in type 1 Gaucher diseaseJournal of Inherited Metabolic Disease, 2010
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in DrosophilaProceedings of the National Academy of Sciences, 2008
- The PINK1/Parkin pathway regulates mitochondrial morphologyProceedings of the National Academy of Sciences, 2008